| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 3.35B | 3.25B | 2.98B | 2.83B | 2.32B | 1.85B |
| Gross Profit | 1.86B | 1.82B | 630.91M | 1.49B | 1.09B | 1.09B |
| EBITDA | 591.52M | 551.20M | 522.16M | 414.52M | 333.56M | 338.56M |
| Net Income | 337.90M | 350.00M | 344.12M | 274.70M | 216.02M | 197.24M |
Balance Sheet | ||||||
| Total Assets | 0.00 | 11.96B | 10.81B | 10.00B | 10.02B | 9.18B |
| Cash, Cash Equivalents and Short-Term Investments | 489.70M | 489.70M | 403.06M | 481.00M | 407.54M | 382.71M |
| Total Debt | 0.00 | 300.00K | 1.15M | 10.10M | 3.03M | 4.21M |
| Total Liabilities | -10.85B | 1.12B | 943.44M | 791.10M | 851.23M | 1.01B |
| Stockholders Equity | 10.85B | 10.85B | 9.87B | 9.21B | 9.17B | 8.17B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 91.70M | 38.16M | 86.30M | -22.10M | 52.50M |
| Operating Cash Flow | 0.00 | 298.60M | 402.68M | 157.00M | 49.13M | 91.70M |
| Investing Cash Flow | 0.00 | -179.10M | -348.64M | -210.10M | 47.99M | 1.80M |
| Financing Cash Flow | 0.00 | -31.20M | -39.36M | -23.80M | -30.72M | -85.80M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
68 Neutral | ₹6.08B | 23.88 | ― | 0.46% | 13.92% | -8.06% | |
66 Neutral | ₹6.45B | 20.74 | ― | 1.90% | 13.38% | 13.98% | |
66 Neutral | ₹5.14B | 16.66 | ― | 3.69% | ― | ― | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
56 Neutral | ₹8.28B | 17.00 | ― | 1.24% | 13.34% | -26.93% | |
55 Neutral | ₹2.38B | -66.63 | ― | 0.22% | 4.26% | -121.56% |
Hindustan Composites Limited has responded to a query from the National Stock Exchange regarding the format and contents of its standalone and consolidated financial results for the quarter and half year ended 30 September 2025. The exchange had observed that the profit and loss figures appeared identical in both sets of results, raising concerns about compliance with the prescribed SEBI format.
In its clarification, the company explained that its share of losses in joint venture Compo Advics (India) Private Limited has exceeded its investment, so in line with IND AS 28 it has stopped recognizing further JV losses in consolidated results since 2021-22. It emphasized that the consolidated results now include a separate line item for the joint venture’s share of loss marked as nil, and that segment assets and liabilities differ between standalone and consolidated statements, asserting overall compliance with SEBI reporting requirements.